Redpin Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 25, 2020
- Vertical
- Gene Therapy
- Funding URL
- View Funding Page
- Funding Amount:
- $15,500,000
Company Info
- Founders
- Elma S. Hawkins
- Company Description
- Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.
- Market
- Central Nervous System Diseases
- Location
- New York, NY, USA
- Coinvestors
- 4BIO Capital, Alexandria Venture Investments, Arkin Bio Ventures, New York Ventures, Takeda Ventures